The comparison with Group A yielded the greatest number (9) of DEGs, with models that were sensitive to DIACC3010 having a greater expression of genes involved in chemokine/cytokine and immune-related signaling and angiogenesis/cancer cell microenvironment (Fig. 8a; CXCL10, CXCL11, IL1A, IL16, S100A12, CLEC7A, VEGFC, WNT4). The gene discussed is VEGFC; the disease is cancer.